Product Information

BUSPIRONE HCL 5 MG TABLET is a generic product labeled by Mylan Institutional LLC, priced at $0.0218 per EA under NDC 51079098520. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Mar 28, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUSPIRONE HCL 5 MG TABLET

buspirone hydrochloride
$0.0218per EA

Strength

5 mg/1

NDC

51079098520

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

BUSPIRONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA076008

FDA Approved

3/28/2001

TE Code

AB

On Market Since

3/25/2002

Price Statistics

The NADAC for BUSPIRONE HCL 5 MG TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 50.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0218 per EA
All-time high$0.0487 (Mar 12, 2014)
All-time low$0.0174 (Nov 20, 2024)
52-week high$0.0221
52-week low$0.0216
Median price$0.0302
Average price$0.0320
Largest weekly change-25.2% (Nov 20, 2024)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-0.5%

3M

+0.9%

6M

-0.7%

1Y

+2.0%

3Y

-12.5%

5Y

-19.4%

All

-50.4%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUSPIRONE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 5 MG TABLET, manufactured by Mylan Institutional LLC, is $0.0218 per EA (NDC 51079098520), effective Nov 11, 2026.

How has the price of BUSPIRONE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUSPIRONE HCL 5 MG TABLET has declined 50.4%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 5 MG TABLET?

Since Nov 28, 2013, the NADAC for BUSPIRONE HCL 5 MG TABLET has ranged from a low of $0.0174 (Nov 20, 2024) to a high of $0.0487 (Mar 12, 2014), with a median of $0.0302 per EA.

Are there cheaper alternatives to BUSPIRONE HCL 5 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUSPIRONE HCL 5 MG TABLET, is $0.0217 per EA — about 0% below BUSPIRONE HCL 5 MG TABLET.

Who manufactures BUSPIRONE HCL 5 MG TABLET?

BUSPIRONE HCL 5 MG TABLET (NDC 51079098520) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.